Page last updated: 2024-11-07

5-fluorodopamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

5-Fluorodopamine is a synthetic analog of dopamine, a neurotransmitter that plays a crucial role in the brain. It is synthesized through a multi-step process that involves the fluorination of dopamine. 5-Fluorodopamine acts as a selective neurotoxin that primarily targets dopaminergic neurons, causing their degeneration. This selective toxicity is attributed to its ability to accumulate in dopaminergic neurons via the dopamine transporter and then induce oxidative stress. 5-Fluorodopamine is a valuable tool in neuroscience research, as it allows scientists to study the role of dopamine in various brain functions and diseases. It is used in animal models to create lesions in dopaminergic pathways, mimicking conditions such as Parkinson's disease. 5-Fluorodopamine research has provided insights into the pathogenesis of neurodegenerative diseases, the development of potential therapeutic strategies, and the understanding of dopamine signaling in the brain.'

Cross-References

ID SourceID
PubMed CID122237
CHEMBL ID41818
SCHEMBL ID1110886
MeSH IDM0093404

Synonyms (13)

Synonym
6-fluorodopamine
bdbm50087510
4-(2-amino-ethyl)-5-fluoro-benzene-1,2-diol
CHEMBL41818 ,
71144-39-3
4-(2-aminoethyl)-5-fluoro-1,2-benzenediol
4-(2-aminoethyl)-5-fluorobenzene-1,2-diol
1,2-benzenediol, 4-(2-aminoethyl)-5-fluoro-
AKOS022189582
SCHEMBL1110886
benzeneethanamine, 2-fluoro-4,5-dihydroxy-
4-(2-aminoethyl)-5-fluoro-1,2-benzenediol #
DTXSID10991450
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)Ki6.00000.00010.949010.0000AID37459
Beta-1 adrenergic receptorRattus norvegicus (Norway rat)Ki41.00000.00000.667310.0000AID40408
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)Ki0.04000.00000.929610.0000AID219797
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)Ki0.04000.00000.970810.0000AID219797
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)Ki0.04000.00000.937510.0000AID219797
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)Ki6.00000.00000.575110.0000AID37459
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)Ki6.00000.00000.965010.0000AID37459
Beta-2 adrenergic receptorCanis lupus familiaris (dog)Ki130.00000.14001.61333.7000AID41478
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
receptor-mediated endocytosisBeta-2 adrenergic receptorCanis lupus familiaris (dog)
regulation of smooth muscle contractionBeta-2 adrenergic receptorCanis lupus familiaris (dog)
positive regulation of MAPK cascadeBeta-2 adrenergic receptorCanis lupus familiaris (dog)
negative regulation of G protein-coupled receptor signaling pathwayBeta-2 adrenergic receptorCanis lupus familiaris (dog)
adenylate cyclase-activating adrenergic receptor signaling pathwayBeta-2 adrenergic receptorCanis lupus familiaris (dog)
positive regulation of autophagosome maturationBeta-2 adrenergic receptorCanis lupus familiaris (dog)
positive regulation of lipophagyBeta-2 adrenergic receptorCanis lupus familiaris (dog)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
beta2-adrenergic receptor activityBeta-2 adrenergic receptorCanis lupus familiaris (dog)
protein homodimerization activityBeta-2 adrenergic receptorCanis lupus familiaris (dog)
norepinephrine bindingBeta-2 adrenergic receptorCanis lupus familiaris (dog)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
early endosomeBeta-2 adrenergic receptorCanis lupus familiaris (dog)
Golgi apparatusBeta-2 adrenergic receptorCanis lupus familiaris (dog)
receptor complexBeta-2 adrenergic receptorCanis lupus familiaris (dog)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID41478Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Syntheses of (R)- and (S)-2- and 6-fluoronorepinephrine and (R)- and (S)-2- and 6-fluoroepinephrine: effect of stereochemistry on fluorine-induced adrenergic selectivities.
AID37459Binding of [3H]prazosin to alpha-1 adrenergic receptor of rat cerebral cortical membranes2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Syntheses of (R)- and (S)-2- and 6-fluoronorepinephrine and (R)- and (S)-2- and 6-fluoroepinephrine: effect of stereochemistry on fluorine-induced adrenergic selectivities.
AID40408Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Syntheses of (R)- and (S)-2- and 6-fluoronorepinephrine and (R)- and (S)-2- and 6-fluoroepinephrine: effect of stereochemistry on fluorine-induced adrenergic selectivities.
AID219797Binding of [3H]clonidine to alpha-2-adrenergic receptor of rat cerebral cortical membranes2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
Syntheses of (R)- and (S)-2- and 6-fluoronorepinephrine and (R)- and (S)-2- and 6-fluoroepinephrine: effect of stereochemistry on fluorine-induced adrenergic selectivities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (75)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (9.33)18.7374
1990's19 (25.33)18.2507
2000's32 (42.67)29.6817
2010's17 (22.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.34 (24.57)
Research Supply Index4.44 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (10.53%)5.53%
Reviews4 (5.26%)6.00%
Case Studies8 (10.53%)4.05%
Observational0 (0.00%)0.25%
Other56 (73.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]